Purchase Order HHSN272201501045P
Award Date
8/17/15
Potential Completion Date
8/21/15
Potential Value
$12K
Federal Agency
NIAID DEA OA Acquisitions
Awardee
Bio X Cell, LLC
Ultimate Awardee
Not listed
PSC Category
6509 - Drugs And Biologicals, Veterinary Use
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
West Lebanon, Lebanon, NH 03784, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Bio X Cell, LLC, a for-profit limited liability company. The $3,770.00 firm fixed price purchase order is for the provision of BIO X CELL RAT IGG1 ISOTYPE CONTROL HRPN and M IFN GAMMA XMG1.2 MG antibodies, which support COVID-19 research as well as research on vaccines and infectious diseases. Bio X Cell has previously provided...
This is a $98,517.25 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and other products supporting life science research and drug discovery. The contract, awarded on January 28, 2021, is for the procurement of COVID-19 research antibodies, with a period of performance through January 26, 2022....
This $9,343.50 firm-fixed-price purchase order was awarded to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products supporting life science research and drug discovery. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS). The award supports Biolegend's provision of specialized products, including oligonucleotide-tagged...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The $16,199.95 contract is for the delivery of BIOLEGEND antibodies to support NIAID's research initiatives, which may include studies related to COVID-19, immunology, and other disease areas. The contract does not...
This is a $18,328.50 firm-fixed-price purchase order contract awarded to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies, by the National Institutes of Health (NIH) Clinical Center. The contract is for the provision of reagents and kits to support various research efforts across disease areas including COVID-19, multiple sclerosis, infectious diseases, allergies, immunology, oncology, and bone marrow disorders. Biolegend has a history of federal awards with the...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $16,345.50 purchase order to Biointron Biological USA Inc. for antibody expression services. As a firm fixed price contract, Biointron will provide the requested antibody expression services to NIH/NIAID at Metuchen, New Jersey from September 19, 2023 through December 29, 2023. No subcontractors or set aside designations were indicated. NIAID conducts and...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The $6,671 firm-fixed-price purchase order is for the supply of ANTIBODIES. Miltenyi Biotec is an experienced federal contractor, having received numerous awards from agencies such as the NIH, Department of Veterans Affairs, Food and Drug Administration, Department of Defense,...
<p>The U.S. National Institutes of Health (NIH) Clinical Center awarded a $11,584.00 firm fixed price purchase order contract to Biorbyt LLC, a woman-owned small business, for the provision of antibody products. The contract has an ultimate completion date of August 8, 2025 and was awarded on August 9, 2024. No set-aside designation was used for this procurement.</p>
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Biolegend, Inc., a for-profit manufacturer of biomedical research products. The contract, valued at $7,190.00, is for the delivery of antibodies. There is no set-aside designation for this contract. Biolegend, Inc. is the prime contractor and has not...
This is a federal contract award to Miltenyi Biotec, Inc., a biotechnology company that provides specialized scientific instruments, reagents, and services to government agencies. The award, valued at $4,563.50, is for the acquisition of antibodies from Miltenyi Biotec. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and is a firm fixed-price purchase order with no set-aside designation. Miltenyi...